Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome

J A Martignetti1, A A Aqeel, W A Sewairi

  • 1Department of Human Genetics, Mount Sinai School of Medicine, Box 1498, Fifth Avenue at 100th Street, New York, New York, USA. john.martignetti@mssm.edu

Nature Genetics
|June 30, 2001
PubMed

Insights

Rare vanishing bone diseases involve bone destruction. Genetic analysis identified mutations in the MMP2 gene, leading to a lack of enzyme activity and causing multicentric osteolysis in Saudi Arabian families.

Area of Science:

  • Genetics
  • Molecular Biology
  • Rheumatology

Background:

  • Inherited osteolyses, or vanishing bone syndromes, are rare disorders characterized by bone destruction and resorption.
  • Multicentric osteolyses present with interphalangeal joint erosions, mimicking severe juvenile rheumatoid arthritis.

Purpose of the Study:

  • To identify the genetic cause of an autosomal recessive form of multicentric osteolysis observed in Saudi Arabian families.
  • To investigate the role of the MMP2 gene in this specific osteolysis syndrome.

Main Methods:

  • Genome-wide search for homozygous-by-descent microsatellite markers in affected families.
  • Haplotype analysis to narrow down the critical genetic region.
  • Mutation analysis and molecular modeling of the MMP2 gene and its protein product.

Main Results:

  • The disease gene was localized to chromosome 16q12-21, specifically within a 1.2-cM region containing the MMP2 gene.
  • Two family-specific homoallelic mutations (R101H and Y244X) in the MMP2 gene were identified.
  • Affected individuals showed no detectable MMP2 enzymatic activity in serum or fibroblasts.

Conclusions:

  • Mutations in the MMP2 gene are causative of this autosomal recessive multicentric osteolysis syndrome.
  • The identified mutations disrupt MMP2 function, leading to bone resorption and associated clinical features.
  • This finding expands the understanding of vanishing bone diseases and the role of MMP2 in skeletal integrity.